Glenmark Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
3,836.12
2,552.11
3,209.08
3,422.48
3,333.50
Other Income Qtr Cr773.1745.411.7020.87-40.21
Operating Revenues Qtr3,062.952,506.703,207.383,401.603,373.72

*All values are in Cr.

Operating Expenses Qtr
2,558.61
2,715.35
2,745.09
2,770.39
2,768.75
Operating Profit Qtr
504.34
-208.65
462.29
631.21
604.97
EBIDT Qtr Cr
855.10
-121.20
257.30
600.06
-234.98
Depreciation Qtr
151.34
147.08
141.45
154.65
146.53
Net Profit Qtr
-1,218.28
-351.38
-81.95
23.19
-428.30
Basic EPS Qtr
-43.18
-12.45
-2.90
5.31
-15.18
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -